ReviewJournal of cellular and molecular medicine2026

Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC.

Daniela Cilloni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.